Since its founding, Kelun Pharmaceuticals has insisted on investing tens of millions of dollars in independent research and development every year, and has fully mastered the core technology of infusion production. Kelun Pharmaceutical Research Institute has been approved as a national post-doctoral research station, and has applied for dozens of patents. Kelun Pharmaceuticals has been rated as a "Key High-tech Enterprise of the National Torch Plan"; in January 2008, Sichuan Kelun Pharmaceuticals Co., Ltd. was rated by the Ministry of Science and Technology of the People's Republic of China as a "National Pilot Innovative Enterprise". "In 2005, Kelun Pharmaceuticals independently researched and developed a number of patented technology "vertical soft bag" infusion successfully launched, the product focuses on the latest achievements of China's contemporary infusion manufacturing technology, representing the future development direction of China's infusion packaging materials, the first of its kind at home and abroad, is profoundly changing the pattern of the infusion industry. It is the first of its kind both at home and abroad, and is profoundly changing the pattern of the infusion industry. "Vertical soft bag" infusion solution has great popularization value in ensuring the safety of people's medication and energy-saving and environmental protection, and has been awarded the title of "High-tech Innovative Product" in Sichuan Province. The product can be air-dropped, in the "5.12" Wenchuan earthquake rescue work played an irreplaceable role, as a "can not be broken" infusion products to the disaster area to implement emergency air-drops, saving countless lives.
As the world's largest professional manufacturer of infusion solutions, Coren Pharmaceuticals' infusion products have an overall market share of more than 20% in the domestic market, with a large number of loyal customer groups, hundreds of millions of audience word-of-mouth so that the Coren brand rock-solid. Kelun Pharmaceuticals products are also exported in bulk, enjoying a good reputation in six overseas markets, including Southeast Asia and Kazakhstan. Kelun Pharmaceuticals through cooperation with the United States SAGENT company *** with the development of the United States infusion products market, set up a new milestone in the quality and reputation of Kelun Pharmaceuticals and the height of the cause of the new milestone.
Keylen Pharmaceuticals upholds the "scientific truth, ethical goodness" business purposes, initially set up the efficiency of the primary distribution, the second distribution of the government's tax-based distribution, the third distribution of social philanthropy as the main awareness of the harmonious development of the third distribution. Over the years, Coren Pharmaceuticals has donated tens of millions of RMB for social welfare, honorable causes and groups in need (among which, the donation to the people in the "5.12" earthquake-stricken areas amounted to 30 million RMB), which demonstrates Coren Pharmaceuticals' concept of wealth quality and sense of social justice, and shows the benign trajectory of the healthy development of an excellent private enterprise under the conditions of the market economy. Especially after the "5.12" Wenchuan Earthquake, Coren Pharmaceuticals went all out with the whole country to fight against the disaster. Coren Pharmaceuticals is the first batch of enterprises in China to contribute generously with all its resources; it is the first batch of enterprises to open up the land route for rescue medicines and implement emergency airdrops; it is the enterprise that insists on production and self-rescue under great pressure during the uninterrupted aftershocks; it is the enterprise that gives the greatest support to all the enterprises, including the international medical team that went to Sichuan to fight against the earthquake and relief disaster. In the midst of the national disaster, the performance of Kelun Pharmaceuticals is outstanding. China Medical News, Pharmaceutical Economy News and other authoritative media have reported in depth on the command efficiency, logistic support, professional ability and fighting spirit of Kelun Pharmaceuticals. Liu Innovation, Chairman of Coren Pharmaceuticals, was also awarded the honorary title of Excellent *** Party Member for Earthquake Relief by Sichuan Provincial Party Committee and Chengdu Municipal Party Committee and Model for Earthquake Relief in Sichuan Province by Sichuan Provincial Party Committee and Provincial Government.
Kelen Pharmaceuticals will make full use of its nationwide marketing and sales network, give full play to the company's technological advantages, product system advantages, quality advantages, raw material supply advantages and strong research and development capabilities that have been formed in the infusion industry, and continue to adjust and optimize the product structure based on the existing production enterprises to further enhance the company's market share in the domestic infusion industry; and at the same time, actively promote the development of non-infusion products, and look for new scale, new products and new products. At the same time, we will actively promote the development of non-infusion products, find new scale and profit growth points, and continuously enhance the company's competitive strength, and strive to become one of the largest, most complete, most profitable and most competitive pharmaceutical manufacturers in China's pharmaceutical industry in 2010.